About Us

Texas A&M University-Corpus Christi (TAMU-CC) is committed to ensuring safeguards in human health and the environment by maintaining adherence with the NIH Guidelines for Research Involving Recombinant DNA Molecules (NIH Guidelines) and the Biosafety in Microbiology and Biomedical Laboratories (BMBL) 6th ed. It is the policy of the university that all research, clinical, and teaching activities involving biohazardous materials be conducted in a safe manner in order to protect the greater community at large, as well as the academic community.

The TAMU-CC Biosafety Program applies to all TAMU-CC faculty, staff, hosted visitors, students, participating guests and volunteers, contract laborers, supplemental personnel, and employees of firms working at locations where TAMU-CC has management control of specific biohazards.

Institutional Biosafety Committee (IBC)

As mandated by the NIH Guidelines, Texas A&M University-Corpus Christi’s Institutional Biosafety Committee is responsible for assessing the biosafety containment level for research involving recombinant DNA and synthetic nucleic acid molecules. The TAMU-CC Institutional Biosafety Committee (IBC) also oversees research with other potentially hazardous biologics. The TAMU-CC IBC currently oversees:

  • Recombinant DNA and synthetic nucleic acid molecules (this includes human gene transfer studies)
  • Infectious agents
  • Biological toxins
  • Human-derived tissues, fluids, and cells
  • Certain animal-derived tissues, fluids, and cells